服务电话:400-621-6806
地址:天津市武清区国际企业社区A5号楼五层,301700
邮箱:info@kmdbioscience.com
产品编号 | YR1468 |
---|---|
产品名称 | Anti-Human CD123 Recombinant Antibody(Talacotuzumab) |
CAS号 | 1826831-79-1 |
抗体亚型 | IgG2 Kappa |
规格 | 1mg, 5mg |
缓冲体系 | PBS, pH7.5 |
产品背景 | Zolbetuximab (development code IMAB362) is an experimental monoclonal antibody against isoform 2 of Claudin-18. It is under investigation for the treatment of gastrointestinal adenocarcinomas and pancreatic tumors. IMAB362 was developed by Ganymed Pharmaceuticals AG. The drug is in phase II clinical trials as of January 2013. |
保存条件 | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |